Abiopharma

General Announcement: Announcement by GuocoLand Limiteds associate, Tower Real Estate Investment Trust ("Tower REIT")

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Change in Interest of Substantial Unitholders

Disclosure of Interest/ Changes in Interest of Trustee-Manager/ Responsible Person: Notification Form for Trustee-Manager in respect of Changes in its Interest (Form 6)

Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies

General Announcement: Payment of Managers Base Fee by way of Issue of Units in Mapletree Industrial Trust

General Announcement: Investments in quoted securities

SES AI Enters into Framework Agreement with Doroni Aerospace to Design and Develop a Battery Pack for Doroni Aerospace’s H1-X Personal eVTOL

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

Total Voting Rights and Capital

Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors